Ajanta Pharma is currently trading at Rs. 440.00, up by 31.10 points or 7.61% from its previous closing of Rs. 408.90 on the BSE.
The scrip opened at Rs. 411.90 and has touched a high and low of Rs. 443.80 and Rs. 404.15 respectively. So far 167302 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 505.00 on 21-Sep-2012 and a 52 week low of Rs. 161.98 on 24-Jan-2012.
Last one week high and low of the scrip stood at Rs. 443.80 and Rs. 390.00 respectively. The current market cap of the company is Rs. 1014.31 crore.
The promoters holding in the company stood at 72.70% while Institutions and Non-Institutions held 1.37% and 25.93% respectively.
Ajanta Pharma has reported results for third quarter ended December 31, 2012.
The company has registered a rise of 75.96% in its net profit at Rs 32.57 crore in Q3FY13 as compared to Rs 18.51 crore in the corresponding quarter previous year. The total income from operation of the company has increased by 39.65% to Rs 229.34 crore for the quarter under review as compared to Rs 164.23 crore in the same quarter last year.
Ajanta Pharma (APL) is engaged manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1854.15 |
Dr. Reddys Lab | 1350.75 |
Cipla | 1497.80 |
Lupin | 2357.65 |
Zydus Lifesciences | 1001.20 |
View more.. |